Methotrexate Polyglutamate Measurements in Patients With Inflammatory Bowel Disease

Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease

NCT00215020 ·Status: COMPLETED

Biofeedback in Pediatric Inflammatory Bowel Disease

NCT04269720 ·Status: WITHDRAWN ·Phase: NA

Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis

NCT04750135 ·Status: UNKNOWN ·Phase: PHASE2

Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With Ulcerative Colitis (UC)

NCT01716039 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

NCT02093663 ·Status: COMPLETED ·Phase: PHASE3

Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

NCT02330653 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease

NCT00946361 ·Status: TERMINATED

Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis

NCT02277470 ·Status: UNKNOWN

Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography

NCT04650867 ·Status: COMPLETED

A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis

NCT01456052 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

NCT05726396 ·Status: WITHDRAWN ·Phase: PHASE2

Reduce Risk for Crohn's Disease Patients

NCT02852694 ·Status: COMPLETED ·Phase: PHASE4

A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease

NCT00606346 ·Status: ACTIVE_NOT_RECRUITING

High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)

NCT05587673 ·Status: COMPLETED ·Phase: PHASE1

An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis

NCT00488774 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative Colitis

NCT04505410 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

NCT01900574 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients

NCT05927064 ·Status: COMPLETED

Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis

NCT04096573 ·Status: WITHDRAWN ·Phase: PHASE2

Ex-vivo Confocal Imaging and Proteomic Profiling to Determine Treatment Response in Children With IBD

NCT07121920 ·Status: NOT_YET_RECRUITING ·Phase: NA

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

NCT02895100 ·Status: TERMINATED ·Phase: PHASE2

Peer Mentoring to Improve Self-management in Youth With IBD

NCT03827109 ·Status: TERMINATED ·Phase: NA

A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

NCT03596645 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases

NCT03640637 ·Status: UNKNOWN

Targeted Metabolomics to Decipher Dietary Contributions to Pediatric Inflammatory Bowel Disease (IBD) - Main Study

NCT05014243 ·Status: UNKNOWN